Search for Teva Pharmaceutical Industries Ltd and
    1. 19 hours ago

      Mylan rounds on Teva as it rejects $40bn bid

      Mylan has rejected a $40bn takeover bid from Israel’s Teva, a generic drugs rival double its size, and confirmed its pursuit...

    2. April 26, 2015

      No end in sight to wave of pharma dealmaking

      Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the...

    1. April 24, 2015

      Three-way merger battle in drugs industry hots up

      Perrigo rejected a formal takeover offer from its bigger generic drugs rival Mylan, escalating a three-way takeover battle...

    2. April 22, 2015

      Mylan readies its poison pill defences

      Israel’s Teva faces an uphill battle in its $40bn takeover pursuit of rival generics drugmaker Mylan, thanks to recent...

    3. April 21, 2015

      Teva seeks cushion against loss of patent protection

      Teva Pharmaceuticals’ $40bn takeover offer for Mylan thrusts into the spotlight a company that has long been a pillar of the...

    4. April 21, 2015

      Teva/Mylan: brand management

      Could a branded drug be the impetus for dealmaking among generics manufacturers? On Tuesday, Israeli Teva Pharmaceutical,...

    5. April 21, 2015

      Harley-Davidson brakes on lower shipment forecasts

      Harley-Davidson shares were on of the biggest decliners on the S&P 500, after the company lowered its 2015 motorcycle...

    6. April 21, 2015

      Israel’s Teva offers $40.1bn for US drugmaker Mylan

      Teva, the largest generic drugmaker in the world, set the stage for the biggest pharma deal of 2015 by launching an...

    7. April 17, 2015

      Mylan dismisses takeover interest from Teva Pharmaceuticals

      Israel’s Teva Pharmaceuticals is considering a bid to acquire rival generic drugmaker Mylan even as the $33bn US company has...

    8. March 30, 2015

      UnitedHealth pays $13bn for drug-benefits manager amid deal flurry

      The largest US health insurer is to spend almost $13bn to buy a company that manages prescription medicines for 35m...

    9. October 3, 2014

      Mylan surges after guidance lift

      Mylan climbed after the Pennsylvania-based pharmaceutical company lifted its third-quarter guidance on recent product...

    10. August 3, 2014

      Private equity eyes drug brands purchase

      Private equity groups are exploring a $10bn plan to buy hundreds of older drug brands from GlaxoSmithKline and Sanofi and...

    11. July 14, 2014

      Teva faces fresh shareholder showdown over management structure

      Teva is facing a fresh confrontation with shareholders after an activist investor accused the drugmaker of reneging on...

    12. July 9, 2014

      European regulators fine Servier of France

      European regulators have fined Servier of France and several other drugmakers €428m for blocking the introduction of cheaper...

    13. June 15, 2014

      Women in Business – Shira Kaplan, MBA student

      Shira Kaplan is an MBA student currently studying on the part-time programme at the University of St Gallen in Switzerland...

    14. May 23, 2014

      Teva: optimism, unfortunately

      Value investing in one tweet: when the worst-case scenario is for sale at fair value, buy it. The primary US patent on the...

    15. May 1, 2014

      Pharma deals reach new level of intensity

      Pfizer wants to buy AstraZeneca, which has been linked with a move for Shire, which is reportedly wanted by Allergan, which...

    16. January 23, 2014

      Teva seeks experience in board shake-up

      Teva has bowed to pressure from activist shareholders, saying it plans to slim down its board and recruit more directors...

    17. January 10, 2014

      Letter from Lex: a new beginning

      Happy Friday, readers. The first week with a new Head of Lex in the London office – an American, no less – is almost past...

    18. January 9, 2014

      Teva names Vigodman as chief executive

      Teva of Israel has sought to draw a line under months of turmoil at the world’s largest generic drugmaker by naming Erez...

    19. January 6, 2014

      Teva: in need of a shot

      The board of Teva Pharmaceuticals is a brains trust of scientific and medical knowledge. Shame that so few of its 16 members...

    20. January 6, 2014

      Teva activist investor backs nomination of Erez Vigodman as chief

      A leading activist shareholder in Teva has lent his support to the proposed nomination of one of the directors of the...

    21. December 29, 2013

      Accusations of insularity and interference haunt the Teva board

      Even by the standards of the regular leaks of sensitive corporate material from Teva, images on Israeli television last...

    22. December 29, 2013

      Teva shareholders press for boardroom shake up

      Leading shareholders in Teva, the world’s largest generic medicines company, are stepping up pressure for a boardroom shake...

    23. December 6, 2013

      How time and focus give non-executives extra oomph

      Hands-off directors and troubled banks seem to go hand in hand – or at least they have this decade. Sir David Walker’s...

    24. December 4, 2013

      Teva interim chief in favour of board diversity

      The interim chief executive of Teva has said he would welcome a more diversified board of directors as the governance of the...

    25. October 31, 2013

      Teva chief leaves as drugmaker struggles to take its medicine

      Wanted: chief executive with global vision, ideas for developing new medicines, experience in cost-cutting, ability to cope...

    26. October 30, 2013

      Teva: a mess, but priced right

      In moments of crisis, leaders say things that are not true. Everyone accepts this. Here, for example, is how Phillip Frost,...

    27. October 30, 2013

      Teva chief executive to step down amid boardroom tensions

      The head of the world’s largest generic drugs company is to step down, less than two years after taking the job in an effort...

    28. October 13, 2013

      Teva: turnabout

      Nostalgia for the financial crisis is rare. But for Teva Pharmaceuticals, the great crash is the good old days. From the...

    29. October 10, 2013

      Drugmaker Teva to cut workforce by 10%

      Teva, the world’s largest generic drugs maker, will sharply reduce its workforce next year as part of intensified...

    30. July 1, 2013

      Drugmakers: binding agents

      Big pharma and generic drugmakers are often at loggerheads. But they may need each other more than they care to admit. Aspen...

    31. June 12, 2013

      Teva and Sun Pharma fined $2.15bn for patent breach

      Generic drug makers Teva and Sun Pharma will pay $2.15bn to Pfizer and Takeda to settle a long-running patent dispute in the...

    32. April 28, 2013

      Teva discovers sophisticated fakes of popular drug

      Leading generic drugmakers are stepping up quality inspections in Europe after unearthing a sophisticated counterfeiting...

    33. December 5, 2012

      Drugs groups aim to halve cost of trials

      Two leading pharmaceutical companies aim to halve the costs of running clinical trials within five years, as they seek to...

    34. November 30, 2012

      Teva restructuring beckons

      Teva, the world’s largest generic drugs company, unveiled 2013 sales and earnings guidance below market expectations,...

    35. October 30, 2012

      Bayer – vitamin A to Z

      Move over pharmaceuticals. Here come “nutraceuticals”. Bayer on Tuesday said it would pay $1.2bn for Schiff Nutrition...

    36. August 14, 2012

      AstraZeneca signs Nexium deal with Pfizer

      AstraZeneca raised its full-year earnings expectations after signing a deal to allow Pfizer the future rights to market an...

    37. August 1, 2012

      Shire beats expectations with ADHD drugs

      Shares in Shire Pharmaceuticals clawed back some of their recent losses after stronger sales of its treatments for attention...

    38. June 25, 2012

      Shire shares slump as rival drug approved

      More than £1bn was wiped from Shire’s market capitalisation on Monday after the US Food and Drug Administration widened the...

    Search for Teva Pharmaceutical Industries Ltd and